Ask AI about Complement pharma
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
0 Reviews
Deutsch
No reviews
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Complement pharma
Complement Pharma is a developer of monoclonal antibody intended to treat neurodegenerative and immune-mediated disorders. The company's monoclonal antibody targets the complement pathway in order to treat immune-mediated disorders, to accelerate nerve regeneration in neurological disorders and drug therapies for neurological disorders, enabling patients to get an early-stage drug that treats and meets the high unmet medical need.
- Website
- complementpharma.com
- Categories
- Biotechnology
